Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for January 2007
January 3, 2007
- Human H5N1 Virus Replikin Count Overtakes That in H5N1 Bird Flu
- Drug Improves Tremors, Involuntary Movements in Parkinson Patients
- Medication Does Not Appear to Offer Benefit for Certain Heart Attack Patients Undergoing Angioplasty or Stent Procedure
January 4, 2007
- Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled Aerovant in Asthma Patients
- Molecular Crosstalk Between Tumor and Surrounding Cells Marks Cancer Progression
- New Details on How the Immune System Recognizes Influenza
- MGI Pharma Announces Publication of Phase 2 Data Describing Dacogen (Decitabine) for Injection in Blood
- D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients
- New Study Reports Preclinical Findings Involving Celsion Heat Activated Liposome
January 5, 2007
- Schwarz Pharma Announces Publication of Rotigotine Data in Neurology
- Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005
- Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs
January 6, 2007
- Genentech Announces Positive Results From a Randomized Phase II Study of Pertuzumab in Combination With Gemcitabine for Advanced Ovarian Cancer
- Hypnion Announces Positive and Robust Phase II Results for Novel Sleep Drug - HY10275
January 9, 2007
- ImClone Systems to Disclose the Result of a Phase III Study before End of Week
- Incyte to Report Positive Preliminary Clinical Results from HIV and Diabetes Programs and Highlight Progress in Several Drug Development Programs at the 25th JPMorgan Healthcare Conference
- Dynavax Reports Interim Tolamba Ragweed Allergy Results From DARTT Trial
- XenoPort Announces Advancements in Clinical Development Programs
- Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of Fentora in Breakthrough Pain
- QuatRx Pharmaceuticals Reports Positive Results From a Phase 2 Trial of Fispemifene
- Myriad Genetics Announces Results of Phase 2 Prostate Cancer Trial
- ProtoKinetix Highlights AAGP Development and Production Strategy
- ProEthic Pharmaceuticals Announces Positive Phase III Clinical Trial Results for Fast-Acting Migraine Product Candidate
- Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis
- Quigley's Broad Spectrum Anti-Viral QR-441(a) Shown to Be Effective Against Two Problematic Pathogens to the Poultry Industry
- Herceptin Improves Early Survival for Women with Breast Cancer
January 10, 2007
- ImmuneRegen BioSciences, Inc. Demonstrates That Viprovex Is a Potential Treatment for Avian and Other Influenzas
- Study Shows Potential of Targeted Microbubbles Using Peregrine's VTA Technology to Identify Which Cancer Patients Would Benefit From Anti-Angiogenesis Therapy
- The Medicines Company's Cleviprex (Clevidipine) Phase III Safety Trials Meet Pre-Specified Objectives
- Benefits of Testosterone Treatment Unknown, Research Shows
January 11, 2007
- SemBioSys' Plant-Produced Insulin Chemically and Physiologically Equivalent to Commercial Insulin in Animal Studies
- Erbitux Meets Primary Endpoint in First-Line Phase III Metastatic Colorectal Cancer Study
- Basilea Announces Positive Top-Line Results On Second Pivotal Phase III Ceftobiprole Trial
- Erbitux Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
- Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Data at Society of Academic & Research Surgery Conference
- Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Data at Society of Academic & Research Surgery Conference
- APR Announces Today Successful Phase III Clinical Trial Results for PRO-513
- Basilea Announces Positive Top-line Results on Second Pivotal Phase III Ceftobiprole Trial
January 12, 2007
- Chelsea Therapeutics Announces Results of European Phase IIb Trial of Droxidopa
- MultiCell Technologies' Proprietary Breakthrough Anti-Cancer Therapy Shown to Prevent Recurrence of Cancer
- Bayer and Onyx Announce Pivotal Nexavar Kidney Cancer Study Published in New England Journal of Medicine
- New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia
- New England Journal of Medicine Reports Aegerion's Lead Compound Reduces LDL By 51% in Patients With a Severe Form of Hypercholesterolemia
- Nutra Pharma Announces Breakthrough Research in the Treatment of Viral Infections
- Positive Results with Rotigotine in Restless Legs Syndrome in Second Phase III Trial
- Women's Response to Anti-HIV Therapy Improved if Treatment Begins Six Months After Earlier Preventive Regimen
January 13, 2007
- Point Therapeutics Provides Preliminary Results from Phase 2 Metastatic Pancreatic Cancer Study
- Study in European Heart Journal Favors TAXUS Stent Over Cypher Stent and Bare-Metal Stents in Diabetic Patients
January 16, 2007
- Novel Compound Affords Protection Against Lethal, Whole-Body Radiation Even When Administered Hours After Exposure!
- New Gene Uncovered for Alzheimer Disease
- Actelion Announces Successful Study with Tracleer in Patients with Mildly Symptomatic Pulmonary Arterial Hypertension
- Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients With Type 1 Gaucher Disease
- New Cancer Drug Shown to Be Active in Patients for the First Time
January 17, 2007
- Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103
- Hollis-Eden Pharmaceuticals Presents Data Demonstrating Discovery of an Endogenous Hormone Potentially Central to Glucose Metabolism
- ArQule Provides Clinical Trial Update
- Viragen Announces That OVA System Results are Published in Leading U.S. Scientific Journal
- Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria
- BioMarin Announces Positive Results From Phase 3 Diet Study of Phenoptin for PKU
- Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
- Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
- Combination of Introgen's Nanoparticles Demonstrate Increased Efficacy in the Treatment of Metastatic Lung Cancer
- MediciNova Announces Results From a Phase II/III Interstitial Cystitis Trial With MN-001
- African-American Heart Attack Survivors Cite Experience as a 'Wake-Up Call' to Address Health and Life Issues
- Pivotal Paper in 'The Oncologist' From National Cancer Institute Predicts Doubling of Cancer Patients
- Study Finds Antivirals Effectively Curb Influenza Virus and Are Valuable in Managing Seasonal Flu in Households
January 18, 2007
- Elixir Pharmaceuticals Presents New Data Highlighting Ghrelin Inhibition as a Potential Method for Regulating Metabolism and Treating Diabetes
- Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
- Metabolex Shows MBX-102/JNJ-39659100 Reduces Inflammation in Preclinical Models of Diabetes
- Evidence Lacking to Support Many Off-Label Uses of Atypical Antipsychotics
- Genaera Corporation Announces Presentation of Data on Trodusquemine Mechanism of Action in Obesity
January 19, 2007
- Anesiva Announces Clinical Data From Phase 1 Trial of 1207
- Protox Reports Promising Interim Results from Prostate Cancer Study
- Cancer Rates Drop for Second Straight Year; Robust Pipeline of New Medicines Offers Even More Hope
- Genetic Signature Predicts Recurrence of Breast, Prostate and Other Cancers, Stanford Researchers Find
- MGI Pharma Announces Publication of Phase 3 Data for Saforis (glutamine) Powder in UpTec for Oral Suspension in Cancer
- Millenia Hope's HIV-1 RNaseH program
- Cetuximab May Prolong Survival for Head and Neck Cancer Patients
- Cetuximab With Radiotherapy Does Not Increase Side Effects for Head and Neck Cancer Patients
January 20, 2007
- S-1 Oral Anticancer Agent Improves Patients' Survival In Adjuvant Gastric Cancer Trial Versus Surgery Alone
- Global Goal to Reduce Measles Deaths in Children Surpassed
- Statin Plus Cancer Drug Deliver Combo Punch to Brain Cancer Cells
- Cetuximab May Prolong Survival for Head and Neck Cancer Patients
- Study Finds Differences between Blood Pressure Medicines and Newly-Diagnosed Diabetes
- Lifestyle Changes Effective in Protecting Against Type II Diabetes
January 23, 2007
- Results Show Xelox (Xeloda plus oxaliplatin) Provides Equivalent Overall Patient Survival Compared to Folfox in Advanced Colorectal Cancer
- Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
- Quigley QR-443 Cachexia Compound Demonstrates Dose Response Effectiveness in Second Preliminary Animal Model Study; Oral Dosing of QR-443 Equally Effective to Intra-Peritoneal Administration in Delaying the Progression of Cachexia in Preliminary Tumor Burden Mouse Model
- Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
- Chemokine Therapeutics to Present Data at the Annuual Meeting of the American Association For Cancer Research on its Lead Drug Candidate, CTCE-9908
- BTG's Plevitrexed Shows Promising Efficacy and Tolerability in a Phase I/II study
- Bioponic Phytoceuticals Announces That Its Curecumin Product May Be an Effective Treatment for Alzheimer's Disease
- Infinity and MedImmune Provide Update On Phase I GIST Trial for IPI-504, a Novel Hsp90 Inhibitor
- Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Capsaicin-induced Pain
- New Study Evaluates Communication About Chemotherapy-Induced Anemia and Fatigue in Clinical Settings
- Callisto Pharmaceuticals Announces Publication of Research Paper on Atiprimod
- Introgen's ADVEXIN Clinical Biomarker Data Presented at Conference on Licensure of Cell and Gene Therapy Products
- Welichem's Anti-cancer Drug Candidate Stimulates the Immune System
- Report Finds Over-the-Counter Drug for Heartburn, Acid Reflux as Effective as Prescription Drugs Costing 10 Times More
January 24, 2007
- Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten
- Publication of Early Research on Callisto Pharmaceutical's Degrasyn Drug Class Suggests Potential to Treat Brain Tumors
- Clinical Pharmacists Can Positively Contribute to Clinical Outcomes for HIV-Infected Patients
- New Data Support Novavax's Pandemic Flu Vaccines
- Researchers Find RegeneRx's TB4 Inhibits Activation of Key Inflammatory Molecule - NFkB
- New Drug Therapy to Combat Graft-vs.-Host Disease in Stem-Cell Patients Shows Significant Reduction in Deaths
- DCA Drug Development Company, CardioMetabolics Inc., Encouraged by Intense Public Interest in Dichloroacetate for Treatment Of Cancer
January 25, 2007
- Phase III Actemra (tocilizumab) Study Results Demonstrate Significant Improvement in Signs and Symptoms of Patients with Rheumatoid Arthritis
- First Actemra Multinational Phase III Trial Demonstrates Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis
- DOR BioPharma to Host Conference Call on Thursday, January 25 to Discuss Recently Published orBec Phase 3 Clinical Results
- Introgen Reports that INGN 241 in Combination with Avastin Results in Complete Tumor Regression
- Newer Class of Antidepressants Similar in Effectiveness, But Side Effects Differ
January 26, 2007
- European Association of Nuclear Medicine Journal Article Reports New Data Regarding Administration of Quadramet with Chemotherapy in Hormone Refractory Prostate Cancer Patients
- The New England Journal Of Medicine Publishes Two Landmark Studies Of Noxafil (Posaconazole) in the Prevention of Invasive Fungal Infections
- Chopping Off Protein Puts Immune Cells Into High Gear
- Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
- Chromos Reports Preclinical Data in Support of CHR-1103 as an Acute Therapy for Relapse Associated with Multiple Sclerosis
- DOR BioPharma to Host Conference Call on Thursday, January 25 to Discuss Recently Published orBec(R) Phase 3 Clinical Results
- Cephalon and National Cancer Institute Report Improved Survival in Newly Diagnosed Adult Patients with Acute Promyelocytic Leukemia in Study Using Trisenox
- Arsenic Compound Improves Survival of Adults with Uncommon Form of Leukemia
- Study Suggests Thrombolysis Therapy with Alteplase Could Be Used Routinely for Stroke Treatment
- Samaritan Pharma's SP-10 Hip On Hep C
